Abbvie Inc

NYSE:ABBV   3:59:59 PM EDT
+2.33 (+1.74%)
4:42:59 PM EDT: $135.73 -0.12 (-0.09%)
Products, Strategic Combinations

Caraway Therapeutics Signs Exclusive, Collaboration And Option Agreement With Abbvie

Published: 06/09/2021 10:52 GMT
Abbvie Inc (ABBV) - Caraway Therapeutics - Signed Exclusive, Collaboration and Option Agreement With Abbvie.
Caraway Therapeutics - Agreement to Develop Novel Small Molecule Therapeutics for Parkinson’s Disease and Other Related Disorders.
Caraway Therapeutics - Under Terms of Agreement, Caraway Will Receive Upfront Cash Payment of $17 Million.
Caraway Therapeutics - Eligible to Receive Up to $267 Million in Payments, Including Upfront and Future Option Payments, and Development Milestones.
Caraway Therapeutics - After Co Completes Certain Pre-clinical Research, Development Activities for Collaboration, Abbvie Has Option to License Program.